During the past decade, Centre Hospitalier d'Abbeville conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier d'Abbeville" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 13 trials, followed by "Centre Hospitalier Universitaire, Amiens" with 8 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 3 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored and "The Lymphoma Academic Research Organisation" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier d'Abbeville" #1 collaborator was "UNICANCER" with 3 trials as a collaborator, "Federation Francophone de Cancerologie Digestive" with 2 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator and "Association de Neuro-Oncologues d'Expression Francaise" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier d'Abbeville" are "Colorectal Cancer" (7 trials), "Cancer" (2 trials), "Pancreatic Cancer" (2 trials), "Advanced Cancer" (1 trials) and "Advanced Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Centre Hospitalier d'Abbeville" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier d'Abbeville" are "Drug" (26 trials), "Other" (6 trials), "Procedure" (3 trials), "Radiation" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (4 trials), "irinotecan hydrochloride" (4 trials), "leucovorin calcium" (4 trials), "Gemcitabine" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier d'Abbeville" are 37 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Hospitalier d'Abbeville". undefined are not yet recruiting, 10 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Centre Hospitalier d'Abbeville, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier d'Abbeville, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".